论文信息 - Capivasertib (AZD5363), an AKT inhibitor, rapidly and effectively targets key AKT pathway and proliferation biomarkers: the STAKT pre-surgical breast cancer study - 字舞流文

Capivasertib (AZD5363), an AKT inhibitor, rapidly and effectively targets key AKT pathway and proliferation biomarkers: the STAKT pre-surgical breast cancer study

D. Rea | J. Robertson | K. Cheung | J. Gee | K. Horgan | R. Coleman | R. Littleford | Bruin | P. Rauchhaus | Chris | Schiavon | S. Cheung | J. Lindemann | L. Koulai | P. Rugman | A. Evans | A. Skene | P. Finlay | R. Deb | M. Pass | M. Cullberg | A. Jahan | A. Foxley | Samreen Ahmed | Holcombe | Elza C de | Gaia